scispace - formally typeset
G

Giuseppina Granato

Researcher at University of Naples Federico II

Publications -  16
Citations -  442

Giuseppina Granato is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Population & Myofibroblast. The author has an hindex of 10, co-authored 14 publications receiving 321 citations.

Papers
More filters
Journal ArticleDOI

Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts.

TL;DR: The wrecking of redox homeostasis in cancer cells and tumor microenvironment induces a metabolic reprogramming in tumor cells and cancer associated fibroblasts, giving advantage to cancer growth.
Journal ArticleDOI

Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts

TL;DR: The study ofCAFs metabolic reprogramming could contribute to better understand their activation process, the interaction between stroma, and cancer cells and could offer innovative tools for the development of new therapeutic strategies able to eradicate the protumorigenic activity of CAFs.
Journal ArticleDOI

Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines.

TL;DR: The data improve the knowledge on the effects of diclofenac and suggest that new anti-neoplastic treatments should be based on the central role of mitochondrion in cancer development; under this concern, the possible involvement of SOD2 as a novel target could be considered.
Journal ArticleDOI

Metabolic flexibility in melanoma: A potential therapeutic target.

TL;DR: The regulation of melanoma metabolic alterations and the metabolic interactions between cancer cells and microenvironment that influence melanoma progression and immune response are described.
Journal ArticleDOI

Optimization of Human Myocardium Decellularization Method for the Construction of Implantable Patches.

TL;DR: Cardiac tissue engineering by means of synthetic or natural scaffolds combined with stem/progenitor cells is emerging as the response to the unsatisfactory outcome of approaches based solely on the principle of cell reprograming.